Apolipoprotein A-I Mimetic Peptide L-4F Removes Bruch's Membrane Lipids in Aged Nonhuman Primates
Author(s) -
Martin Rudolf,
Christine A. Curcio,
Ursula SchlötzerSchrehardt,
Armin Mir Mohi Sefat,
Aysegül Tura,
Zouhair Aherrahrou,
Max Brinkmann,
Salvatore Grisanti,
Yoko Miura,
Mahdy Ranjbar
Publication year - 2019
Publication title -
investigative ophthalmology and visual science
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.18-25786
Subject(s) - bruch's membrane , drusen , macular degeneration , retinal pigment epithelium , retinal , ophthalmology , pathology , chemistry , medicine , biology
Multiple evidence lines support Bruch's membrane lipid deposition as a major precursor of soft drusen and age-related macular degeneration as including a potentially treatable atherosclerosis-like progression in the subretinal pigment epithelium (RPE)-basal lamina space. We evaluated the effect of anti-inflammatory, antiatherogenic peptide L-4F on Bruch's membrane of aged nonhuman primates in a dose-escalating study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom